Diabetes Drug Metformin Could Cut Risks for Long COVID-19, Says Study
Metformin - a drug commonly used to treat diabetes, prevents the development of long COVID, a new study published in The Lancet Infectious Diseases, University of Minnesota has found. According to the research – called COVID-OUT,
Diabetes Med Metformin Could Cut Risks for Long COVID
One of the most common diabetes drugs, metformin, might deliver an added bonus: Lowering users' odds for Long COVID
Use of metformin in adults with diabetes linked to lower risk of long COVID
Adults who use the prescription drug metformin to treat their type 2 diabetes have a lower risk of developing long COVID or dying after a COVID-19 infection than people with diabetes who take other anti-diabetes medications,
Metformin Use in Diabetics Tied to Lower Long COVID Risk
Adults who use the prescription drug metformin to treat their type 2 diabetes have a lower risk of developing long COVID or dying after a COVID-19
NIH Reports the Use of Metformin in Adults with Diabetes Linked to Lower Risk of Long COVID
Large NIH-funded study supports previous studies showing potential benefit.
Research shows diabetes drug could reduce dementia risk. Here’s how the two diseases may be linked
Some diabetes meds might lower risk of dementia, Parkinson's
A specific class of diabetes drug appears to lower people's risk for dementia and Parkinson's disease, a new study shows.
Some diabetes medications linked to lower dementia, Parkinson's disease risk
Gliflozins, another name for sodium-glucose cotransporter-2 (SGLT2) inhibitors, were the subject of the investigation. By encouraging the kidneys to eliminate sugar from the body through urine, they reduce blood sugar.
Type 2 drugs could lower dementia, Parkinson's disease risk
Researchers have found that people who take a type of type 2 diabetes drugs SGLT2 inhibitors have a significantly lower risk of dementia, overall, and of Alzheimer's disease and Parkinson's, in particular.
McKnight's Long-Term Care News2d
Metformin use tied to lower incidence of death, long COVID after COVID-19
After COVID infection, prevalent metformin use is associated with a slightly lower incidence of death or postacute sequalae of SARS-CoV-2.
World Socialist Web Site17d
Metformin and COVID-19: An old drug with compelling anti-viral properties
The analysis of the impact of metformin on Long COVID was published in Lancet Infectious Diseases, showing that the drug metformin lowered one’s risk of developing Long COVID by 41.3 ...
U.S. News & World Report4d
Diabetes Med Metformin Could Cut Risks for Long COVID
THURSDAY, Sept. 19, 2024 (HealthDay News) -- One of the most common diabetes drugs, metformin, might deliver an added bonus: Lowering users' odds for Long COVID. Long COVID can present ...
KTBS4d
Diabetes Med Metformin Could Cut Risks for Long COVID
There's new data supporting the notion that the widely used diabetes drug metformin can cut users' odds for Long COVID The drug also reduced the odds that a person with type 2 diabetes would die ...